Clinical trials
Withdrawn Carcinoma, Non-Small-Cell Lung trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 4 |
| 2008 | 5 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 4 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 5 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 81 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Case Comprehensive Cancer Center | 3 |
| M.D. Anderson Cancer Center | 3 |
| Roswell Park Cancer Institute | 3 |
| University of California, San Francisco | 3 |
| Eli Lilly and Company | 2 |
| Fox Chase Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Spectrum Pharmaceuticals, Inc | 2 |
| University of Southern California | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 81 |
| Lung Neoplasms | 31 |
| Adenocarcinoma of Lung | 7 |
| Neoplasm Metastasis | 5 |
| Brain Neoplasms | 4 |
| Breast Neoplasms | 4 |
| Neoplasms | 3 |
| Small Cell Lung Carcinoma | 3 |
| Adenocarcinoma, Bronchiolo-Alveolar | 2 |
| Colonic Neoplasms | 2 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.